Comment on "Flagellin as an adjuvant: cellular mechanisms and potential".
Janardan P
JP
Pandey
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000378:metabolism*; D000818:Animals; D000918:Antibody Specificity / Q000235:genetics; D001666:Binding Sites, Antibody / Q000235:genetics; D017321:Clinical Trials, Phase I as Topic; D018985:Epitopes, B-Lymphocyte / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D005408:Flagellin / Q000009:adverse effects / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000378:metabolism; D007129:Immunoglobulin Gm Allotypes / Q000009:adverse effects / Q000378:metabolism*; D051379:Mice
D000276:Adjuvants, Immunologic; D018985:Epitopes, B-Lymphocyte; D007074:Immunoglobulin G; D007129:Immunoglobulin Gm Allotypes; D005408:Flagellin